tiprankstipranks
Trending News
More News >
Advertisement
Advertisement
Eli Lilly upgraded to Buy from Hold at Freedom Capital
PremiumThe FlyEli Lilly upgraded to Buy from Hold at Freedom Capital
5d ago
Lilly Advances Eloralintide Into Phase 3, Expanding Its Obesity Drug Ambitions
Premium
Company Announcements
Lilly Advances Eloralintide Into Phase 3, Expanding Its Obesity Drug Ambitions
5d ago
Eli Lilly’s Solbinsiran Trial Advances in High-Risk Cholesterol Market
Premium
Company Announcements
Eli Lilly’s Solbinsiran Trial Advances in High-Risk Cholesterol Market
5d ago
Unusually active option classes on open February 9th
PremiumThe FlyUnusually active option classes on open February 9th
6d ago
Morning Movers: Hims & Hers drops after deciding to stop selling Wegovy copycat
Premium
The Fly
Morning Movers: Hims & Hers drops after deciding to stop selling Wegovy copycat
6d ago
Eli Lilly to acquire Orna Therapeutics for up to $2.4B
Premium
The Fly
Eli Lilly to acquire Orna Therapeutics for up to $2.4B
7d ago
Bristol Gate Capital Partners Trims Eli Lilly Stake
PremiumCompany AnnouncementsBristol Gate Capital Partners Trims Eli Lilly Stake
7d ago
Eli Lilly Earnings Call Highlights Hyper-Growth Momentum
Premium
Company Announcements
Eli Lilly Earnings Call Highlights Hyper-Growth Momentum
7d ago
FDA Crackdown on Compounded GLP-1s Strengthens Eli Lilly’s Obesity and Diabetes Franchise, Supporting Buy Rating
Premium
Ratings
FDA Crackdown on Compounded GLP-1s Strengthens Eli Lilly’s Obesity and Diabetes Franchise, Supporting Buy Rating
7d ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100